Congress Gives Jeff Sessions $0 To Go After Medical Marijuana Laws


WASHINGTON ― Congress, once again, is blocking the Justice Department from spending any money that interferes with state medical marijuana laws.

In their newly unveiled budget bill, lawmakers included a provision, known as the Rohrabacher-Farr amendment, that allows states to carry on with crafting their own medical marijuana policies without fear of federal intervention. The bill, which funds the government through the end of September, is expected to pass this week.

Here’s the full text of the marijuana provision:

None of the funds made available in this Act to the Department of Justice may be used, with respect to any of the States of Alabama, Alaska, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming, or with respect to the District of Columbia, Guam, or Puerto Rico, to prevent any of them from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana.

It’s not unusual to find this tucked into a budget bill; lawmakers have been renewing the medical marijuana provision in every consecutive budget since it first passed in 2014. But what it shows is that Congress isn’t interested in stepping up federal oversight of state pot laws under the Trump administration, even as U.S. Attorney General Jeff Sessions hints that he wants a crackdown.

He issued an ominous warning in February to states with legalized marijuana. “States, they can pass the laws they choose,” Sessions said at a Justice Department press briefing. “I would just say it does remain a violation of federal law to distribute marijuana throughout any place in the United States, whether a state legalizes it or not.”

He has also said that “good people don’t smoke marijuana” and that pot is only “slightly less awful” than heroin. Last year, heroin killed nearly 13,000 people. Nobody has ever died from a marijuana overdose.

Attorney General Jeff Sessions may not like that some states have legalized marijuana. But he’s outnumbered.

Jeffrey Zucker, president of the cannabis business strategy firm Green Lion Partners, praised lawmakers for sticking with the status quo.

“Medical cannabis patients in the U.S. can rest easy knowing they won’t have to return to the black market to acquire their medicine,” Zucker said. “Operators can relax a bit knowing their hard work isn’t for naught and their employees’ jobs are safe.”

In theory, Sessions could still take action against states that have legalized recreational marijuana. Eight states and the District of Columbia have laws like this, and they are not shielded by the language in the budget bill.

And while medical marijuana is legal in 29 states and the District of Columbia (and another 15 states have laws allowing limited use of cannabidiol, or CBD, the non-psychoactive ingredient in pot that holds promise for therapeutic use), cannabis is still illegal at the federal level. That’s why proponents of medical marijuana are thrilled by the ongoing legislative caveat, but ultimately have their sights set on changing the law.

“While this is great as a continuing step, it’s important for activists and the industry to remain vigilant and getting cannabis federally unscheduled and truly ending the prohibition of this medicinal plant,” Zucker said.

Source: [ ]

Groundbreaking Study On Marijuana Use Coincides With World Cannabis Day, 4/20


Just in time for 4/20 or World Cannabis Day, DIG Insights, a leading global research firm, has released its Cannabis Culture Report, an extensive research initiative on marijuana use in North America encompassing public attitudes on usage, legalization and much more.

Experience the interactive Multimedia News Release here:


E-Cigs and Cannabis Oil Cartridges May Pose Health Risks

Medical Information, News

For months at Cannaceutics, we have heard questions about whether we carry pre-filled cannabis oil cartridges for vape pens. Cannaceutics planned on bringing the cartridges in later in 2017, but there are rumors in the industry that the product inhaled from the cartridges may not be safe.
Read more

Cannabis 101: A Beginner’s Guide


For first-time medical cannabis patients who have no other experience with cannabis, the process of selecting medicine for the first time can be intimidating. The modern cannabis industry has progressed far beyond simply choosing between indica and sativa medicine, and there are more choices for how to ingest your medicine than ever. This guide is meant as a basic reference for first-time patients and it should be noted that while many aspects of cannabis are common among users, every patient is different and will process cannabinoids differently. Cannaceutics encourages you to start slowly, and “check in” with yourself often to see how you’re feeling, both mentally and physically, to avoid overmedicating. Read more

Bipartisan “Path to Marijuana Reform” bills introduced to decriminalize, protect, regulate cannabis industry


Three marijuana-related bills address issues such as taxation, banking, civil forfeiture, de-scheduling, decriminalization, research, individual protections and regulation
Read more